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RECEIVED DATE 
Abstract. A palladium-catalyzed reaction of preparing various endocyclic allenes was developed. The 
substrates for the reaction were readily available w-(pronucleophile-tethered)-3-bromo-1,3-alkadienes,
and a palladium-catalyst facilitated their unimolecular SN2'-cyclization in the presence of potassium tert-
butoxide to give the corresponding 9- to 16-membered endocyclic allenes in fair yields of up to 67% 
together with the dimeric 16- to 32-membered endocyclic bis-allenes and other oligomeric/polymeric 
intermolecular reaction products. For higher yields of the monomeric endocyclic allenes, the reaction 
needed to be conducted under high-dilution conditions. Using a chiral palladium-catalyst, axially chiral 
endocyclic allenes were obtained in up to 70% ee. 
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Introduction 
Allenes are a class of compounds characterized by two cumulated carbon-carbon double bonds. Due 
to the propadiene structures, they show distinctive steric and electronic properties and have emerged as 
highly interesting target molecules in organic synthesis.1,2 Incorporation of an allenic substructure into a 
carbocycle creates a peculiar topological property.3 Although various endocyclic allenes have been 
prepared and reported so far, most of their synthetic methods construct an allenic motif within a 
preformed carbocycle precursor.4-6 Two of the most widely applicable methods in the synthesis of 
endocyclic allenes, namely the ring enlargement of cycloalkenes via the corresponding gem-
dibromobicyclo[n.1.0]alkenes by the Doering-Moore-Skattebøl reaction4 and dehydrohalogenation of 1-
halocycloalkenes,5 are also classified to this category. Another approach to the endocyclic allenes is 
cyclization of preformed acyclic allenes.7 This approach, however, is not applicable to the synthesis of 
relatively smaller-ring cyclic allenes. The third category of the endocyclic allene synthesis is 
simultaneous construction of both allenic and cyclic structures by a single process, but the reported 
examples in this category are very rare.8 Since 2000, we have developed a palladium-catalyzed reaction 
of preparing functionalized allenes starting with 2-halo-1,3-dienes and appropriate soft nucleophiles (eq 
1 in Scheme 1).9 The reaction was extended into an asymmetric counterpart by the use of a chiral Pd 
catalyst, and enantiomerically enriched axially chiral allenes were obtained in up to 94% ee.10 We also 
demonstrated that the palladium-catalyzed reaction could be used for the synthesis of a series of 
endocyclic allenes starting with cycloalkenones.9b 
 
Scheme 1. Palladium-Catalyzed Reaction of 2-Halo-1,3-dienes with Soft Nucleophile 
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In this report, we would like to describe a novel method of preparing various endocyclic allenes 
utilizing the Pd-catalyzed reaction. The two reactants of the palladium-catalyzed reaction, namely a 2-
bromo-1,3-diene and a soft nucleophile, are incorporated into a single molecule and the SN2'-cyclization 
of the "ambivalent" substrates proceeds primarily intramolecularly to afford various endocyclic allenes 
in fair yields. 
The allenic substructure, which is with two cumulated orthogonal carbon-carbon double bonds, 
suppresses the relative motion among the five consecutive atoms (marked in red; eq 2 in Scheme 1). 
Similarly, the relative orientation of the five atoms is fastened in the (alkylidene-p-allyl)palladium 
intermediate of the palladium-catalyzed reaction.11 These rigid substructures in the palladium-
intermediates as well as in the allenic products may lead to the unusual preference/selectivity in the 
present cyclization reactions. Indeed, the cyclization process could provide various medium- to large-
carbocycles in reasonable yields. It should be mentioned that formation of five- to seven-membered 
carbocycles, which are easy to be assembled in typical cyclization processes, are impractical by the 
present method, because thermodynamically stable endo-carbocyclic allenes are usually nine-membered 
or larger.12 Although a few kinetically stabilized eight-membered carbocyclic allenes were reported to be 
isolable,13 endocyclic allenes with a seven-membered or a smaller carbocycle exist only as transient 
reactive intermediates. 
 
Results and Discussion 
Preparation of Pronucleophile-Tethered 3-Bromo-1,3-diene Derivatives 3 and 4. The substrates 
for our endocyclic allene synthesis are pronucleophile-tethered 3-bromo-1,3-dienes (3a-h and 4f), and 
they are prepared from w-bromoalkanals by the simple three-step sequence as depicted in Scheme 2. 
Readily available w-bromoalkanals were converted into the corresponding 1,1,w-tribromoalkenes 1a-i 
in 61-77% yields by the standard Wittig dibromoolefination (Ramirez olefination).14 The palladium-
catalyzed cross-coupling of 1 with vinylzinc chloride proceeded at the sterically less congested alkenyl-
Br (i.e., C=CBr trans to the w-bromoalkyl group) selectively to give the corresponding (Z)-3,w-
dibromo-1,3-dienes 2a-h in 50-68% yields.15 Alkylation of dimethyl malonate or benzodithiole 
tetraoxide (BDT) with 2 furnished designed substrates 3a-h and 4f in pure form (70-95%). 
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Scheme 2. Preparation of Pronucleophile-Tethered 3-Bromo-1,3-dienes 
 
 
Palladium-Catalyzed Reactions of Pronucleophile-Tethered 3-Bromo-1,3-diene Derivatives 3 
and 4. Substrates 3 and 4 prepared as in Scheme 2 were subjected to the palladium-catalyzed reaction. 
At the outset, the conditions for the palladium-catalyzed reaction were optimized using 3e (n = 7) as a 
model substrate, and the results of the optimization studies are summarized in Table 1. The reaction of 
3e was efficiently catalyzed by 5 mol % of a palladium complex generated in situ from Pd2(dba)4 and 
dpbp16 (1.1 equiv to Pd) in THF in the presence of potassium tert-butoxide (1.1 equiv to 3e). Under the 
rather standard conditions, i.e. with the initial concentration of substrate 3e being 1.4 × 10–2 mol/L, 3e 
was completely consumed within 20 h at 30 °C. However, to our disappointment, yield of desired 12-
membered endocyclic allene 5e was only 9% (entry 1). Complete consumption of 3e and the low yield 
of 5e indicated that intermolecular processes giving oligomeric/polymeric products competed with the 
unimolecular cyclization reaction. Indeed, reactions under dilute conditions facilitated the desired 
intramolecular pathway leading to the higher yields of 5e (entries 2 and 3). When the initial 
concentration of 3e was 1.4 × 10–3 mol/L, 5e was isolated in 31% yield (entry 3). It should be mentioned 
that the reactions in entries 1-3 produced dimeric endocyclic bis-allene 6e in 11-19% yields together 
with 5e. Endocyclic bis-allene 6e was obtained as a mixture of dl- and meso-diastereomers with respect 
to the allenic axial chirality; two allenic central sp-C signals were detected at d 205.8 and 205.9 in the 
13C-NMR spectrum (see Experimental Section).17 THF was the best solvent examined so far. Reactions in 
DMF, toluene, or dichloromethane gave 5e in much lower yields ranging 0-8% (entries 4-6). The choice 
of a proper base drastically influences the yield of 5e; while the reactions with KOtBu or NaOMe 
afforded the monomeric endocyclic allene in 31% yield (entries 3 and 7), the yield of 5e declined to 
16% by the use of CsOtBu (entry 8), and the reaction using Cs2CO3 did not provide 5e at all (entry 9). 
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On the other hand, the effects of the bisphosphine ancillary ligands were minor, and the reactions with 
DPEphos18 (1.1 equiv to Pd) or dppf gave 5e in 23% and 25% yields, respectively (entries 10 and 11). 
 
Table 1. Optimization of Reaction Conditions for Palladium-Catalyzed SN2'-Cyclization of 3e.a 
 
entry solvent base ligand conc. of 3e (mol/L) yield of 5e (%) yield of 6e (%)b 
1 THF KOtBu dpbp 1.4 × 10–2 9c 13c 
2 THF KOtBu dpbp 1.4 × 10–2 22c 11c 
3 THF KOtBu dpbp 4.6 × 10–3 31c 19c 
4 DMF KOtBu dpbp 1.4 × 10–3 8d n.d.e 
5 toluene KOtBu dpbp 1.4 × 10–3 7d n.d.e 
6 CH2Cl2 KOtBu dpbp 1.4 × 10–3 0d n.d.e 
7 THF NaOMe dpbp 1.4 × 10–3 31c 15c 
8 THF CsOtBu dpbp 1.4 × 10–3 16d n.d.e 
9 THF Cs2CO3 dpbp 1.4 × 10–3 0 n.d.e 
10 THF NaOMe DPEphos 1.4 × 10–3 23d n.d.e 
11 THF NaOMe dppf 1.4 × 10–3 25d n.d.e 
a The reaction was carried out with 3f (140 µmol) and a base (154 µmol) in the given solvent at 30 °C 
for 20 h in the presence of a palladium catalyst (5 mol %) generated from Pd2(dba)4 and a bisphosphine 
ligand. b Obtained as dl/meso-diastereomeric mixtures (footnote 17). c Isolated yield by recycle HPLC. d 
Determined by GC analysis. e Not determined. 
 
The reaction conditions shown in entry 3 of Table1 were selected as "optimized conditions" and they 
were applied to the other substrates in the same way. The results of the palladium-catalyzed reaction are 
summarized in Table 2.  
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While the substrates with more than three methylene units (i.e., 3b and the longer ones) afforded the 
corresponding monomeric endocyclic allenes 5b-h in moderate yields by the palladium-catalyzed 
reaction, the reaction of 3a did not provide eight-membered endocyclic allene 5a (entry 1). The highest 
yield of 5 was achieved for the reaction of 3f giving thirteen-membered monomeric endocyclic allene 5f 
in 52% yield (entry 6). With a longer polymethylene chain in 3g (n = 9) and 3h (n = 11), the yields of 
5g (42%) and 5h (33%) were slightly lower (entries 7 and 8). Likewise, shorter substrates 3b-e afforded 
the corresponding monomeric endocyclic allenes 5b-e in lower yields ranging 11% to 31% (entries 2-5). 
In all the cases including the reaction of 3a, substrates 3 were completely consumed under these 
conditions, and the formation of dimeric endocyclic bis-allenes 6, which were isolated in 10-30% yields 
by the HPLC separation, was observed. Homologous trimeric endocyclic tris-allenes 7a, 7c, and 7d 
were also isolated in 10%, 7%, and 9% yields, respectively, in the reactions giving 6 in relatively higher 
yields (entries 1, 3, and 4). Since bis-allenes 6 and tris-allenes 7 possess multiple allenic axially chiral 
elements, they were obtained as diastereomeric mixtures.17 
 
Table 2. Influences of Ring Size in Palladium-Catalyzed SN2'-Cyclization of 3.a 
 
entry substrate 3 yield of 5 (%)b yield of 6 (%)b,c,d yield of 7 (%)b,c,d 
1 3a (n = 3) 0 (5a) 30 (6a) 10 (7a) 
2 3b (n = 4) 23 (5b) 16 (6b) ----e 
3 3c (n = 5) 11 (5c) 24 (6c) 7 (7c) 
4 3d (n = 6) 18 (5d) 27 (6d) 9 (7d) 
5 3e (n = 7) 31 (5e) 19 (6e) ----e 
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6 3f (n = 8) 52 (5f) 14 (6f) ----e 
7 3g (n = 9) 42 (5g) 21 (6g) ----e 
8 3h (n = 11) 33 (5h) 10 (6g) ----e 
a The reaction was carried out with 3 (350 µmol) and a base (385 µmol) in THF (250 mL) at 30 °C for 
20 h in the presence of a palladium catalyst (5 mol %) generated from Pd2(dba)4 and dpbp. b Isolated 
yield by recycle HPLC. c Calculated based on 3. d Obtained as diastereomeric mixtures (footnote 17). e 
Not determined or <5% yield. 
 
Whereas eight-membered endo-carbocyclic allenes are generally too reactive to be isolated without 
appropriate kinetically stabilizing bulky substituents,3a,e,13 it was rational that 5a was not detected in the 
reaction of 3a. However, the absence of 5a should not be ascribed to its high reactivity. Once highly 
reactive 5a was generated in situ, it was expected to undergo [2+2]cycloaddition19 giving an isomeric 
mixture of homodimers such as 8, but 8 and/or related isomeric species were not detected in the reaction 
mixture. The key intermediate of the palladium-catalyzed reaction of 3a is (alkylidene-p-allyl)palladium 
species 9. Due to the short trimethylene chain in 9, the nucleophilic malonate moiety is not capable of 
attacking the CH2 p-allyl terminus intramolecularly, and thus the formation of 5a could not be realized  
(Scheme 3). 
 
Scheme 3.  
 
 
The cyclization reaction of 4f was also examined. Substrate 4f possesses a benzo[1,3]dithiole 
tetraoxide (BDT) substructure as a pronucleophilic moiety. The palladium-catalyzed reaction of 4f was 
conducted essentially in the same way as in Table 2 except for the reaction time. Due probably to the 
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lower nucleophilicity of BDT, the reaction took longer time (120 h) for completion, and monomeric 
endocyclic allene 10f was obtained in the highest yield of 67% (Scheme 4). The formation of the 
corresponding endocyclic dimeric bis-allene and trimeric tris-allene was minor (<5%) in this reaction. 
The BDT moiety in 4f is sterically more compact than the malonate moiety in 3f, which may facilitate 
the intramolecular cyclization in the palladium-catalyzed process.  
 
Scheme 4. Palladium-Catalyzed SN2'-Cyclization of BDT-Tethered Substrate 4f. 
 
 
Palladium-Catalyzed Asymmetric Synthesis of Axially Chiral Endocyclic Allenes 5f and 10f. 
Endocyclic allenes 5 and 10 obtained as in Table 2 and Scheme 4 are axially chiral but racemic. Using 
3f as a representative substrate, palladium-catalyzed enantioselective synthesis of 5f was examined 
according to our previous studies.10 That is, with a palladium catalyst (5 mol %) generated from 
Pd2(dba)4 and (R)-segphos ((R)-L1) in THF at 30 °C in the presence of KOtBu, (+)-5f was obtained in 
50% yield with 65% ee (Table 3, entry 1). Among the various solvents and bases examined, the 
combination of THF and KOtBu showed the highest yield and the highest enantioselectivity for the 
reaction of 3f (entries 1-5). While (R)-L2, (R)-L4, and (R)-L5 showed lower enantioselectivity than 
(R)-L1 with 45-55% ee (entries 6, 8, and 9), the enantioselectivity was improved to 70% ee by the use 
of (R)-L3 although the chemical yield of (+)-5f was considerably lower (entry 7). The enantioselective 
reaction of 4f was conducted as in entry 7 and (+)-10f was obtained in 51% ee and 29% yield (entry 10). 
The absolute configurations of dextrorotatory (+)-5f and (+)-10f were deduced to be (S) by the Lowe-
Brewster rule.20 
 
Table 3. Palladium-Catalyzed Asymmetric Synthesis of Axially Chiral Endocyclic Allenes 5f/10f.a 
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entry substrate chiral ligand base solvent yield (%)b % ee (config)c,d 
1 3f (R)-L1 KOtBu THF 50 (5f) 65 (S) 
2 3f (R)-L1 KOtBu dioxane 5 (5f) 11 (S) 
3 3f (R)-L1 KOtBu CH2Cl2 n.d.e –––– 
4 3f (R)-L1 NaOMe THF 13 (5f) 59 (S) 
5 3f (R)-L1 CsOtBu THF 35 (5f) 55 (S) 
6 3f (R)-L2 KOtBu THF 42 (5f) 45 (S) 
7 3f (R)-L3 KOtBu THF 25 (5f) 70 (S) 
8 3f (R)-L4 KOtBu THF 34 (5f) 55 (S) 
9 3f (R)-L5 KOtBu THF 54 (5f) 50 (S) 
10 4f (R)-L3 KOtBu THF 29 (10f) 51 (S) 
a The reaction was carried out with 3f or 4f (100 µmol) and a base (110 µmol) in a given solvent (70 
mL) at 30 °C for 60 h in the presence of a palladium catalyst (5 mol %) generated from Pd2(dba)4 and a 
chiral ligand L. b Isolated yield by recycle HPLC. c Determined by chiral HPLC analysis (see 
Experimental Section for details). d The absolute configurations were deduced by the Lowe-Brewster 
rule (ref 20). e Not determined. 
 
Conclusions 
In summary, we have developed a general method of preparing various endocyclic allenes of a nine- 
to sixteen-membered carbocycle utilizing the palladium-catalyzed reaction. Readily available w-
(pronucleophile-tethered)-3-bromo-1,3-alkadienes 3 and 4 undergo the unimolecular SN2'-cyclization in 
the presence of an appropriate palladium catalyst to give the corresponding endocyclic allenes 5/10 in 
fair yields together with the dimeric endocyclic bis-allenes and higher oligomers/polymers. The highest 
yield of 67% was achieved for the preparation of the thirteen-membered cyclic allene. Due probably to 
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the rigid substructures in the allenic C=C=C products as well as in the (alkylidene-p-allyl)palladium 
intermediates, the medium- to large-membered carbocyclic compounds are accessible in reasonable 
yields by the present cyclization reaction. By the use of a chiral palladium-catalyst, axially chiral 
endocyclic allenes were obtained in up to 70% ee. 
 
Experimental Section 
General. All anaerobic and/or moisture sensitive manipulations were carried out with standard 
Schlenk techniques under predried nitrogen or with glovebox techniques under prepurified argon. 1H 
NMR (at 400 MHz) and 13C NMR (at 100 MHz) chemical shifts are reported in ppm downfield of 
internal tetramethylsilane. The HRMS measurements were carried out by the EI method with a TOF 
analyzer. Tetrahydrofuran (from benzophenone-ketyl) and dichloromethane (from CaH2) were distilled 
under nitrogen prior to use. Pd(PPh3)4,21 Pd2(dba)4,22 dpbp,16 (R)-L1,23 (R)-L2,24 (R)-L4,25 (R)-L5,26 and 1,3-
benzodithiole-1,1,3,3-tetraoxide (BDT)27 were prepared according to the reported methods. All the other 
chemicals were obtained from commercial sources and used as received unless otherwise noted. 
Preparation of w-Bromoalkanals. The w-bromoalkanals were prepared from the corresponding 
commercially available w-bromo-1-alkanols according to the reported procedure,28 in which the 
preparation of 8-bromooctanal (n = 7 in Scheme 2) was described in detail. All the w-bromoalkanals 
used in this study are known compounds and were characterized by comparison of their NMR spectra 
with those reported previously (n = 3,29 n = 4,29 n = 5,30 n = 6,31 n = 7,28 n = 8,32 n = 9,32 n = 1133). 
Preparation of 1,1,w-Tribromo-1-alkenes (1a-h). To a CH2Cl2 (ca. 2 mL/w-bromoalkanal 1 mmol) 
solution of CBr4 (1.5 equiv to w-bromoalkanal) was added PPh3 (3.0 equiv to w-bromoalkanal) 
portionwise at 0 °C, and the solution was kept stirring at this temperature for 20 min. A solution of w-
bromoalkanal (1 equiv) in CH2Cl2 (ca. 1 mL/w-bromoalkanal 2 mmol) was added dropwise at 0 °C, and 
the mixture was stirred at the same temperature for 10 min. After quenching the reaction mixture with a 
small amount of water (ca. 1 mL), the mixture was concentrated under reduced pressure. Addition of 
hexane (ca. 5 mL/w-bromoalkanal 1 mmol) to the concentrated solution precipitated triphenylphosphine 
oxide as pale yellow solid, which was removed by filtration. The filtrate was evaporated, and the 
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residue was purified by silica gel column chromatography (with hexane). The characterization data of 
1a-h are given below. 
1,1,5-Tribromo-1-pentene (1a; n = 3). Colorless liquid. Yield: 6.27 g (63%) starting with 4-
bromobutanal (4.90 g; 32.5 mmol). 1H NMR (CDCl3): d 1.96-2.03 (m, 2H), 2.25-2.31 (m, 2H), 3.42 (t, J 
= 6.6 Hz, 2H), 6.40 (t, J = 7.3 Hz, 1H). 13C{1H} NMR (CDCl3): d 30.8, 31.7, 32.5, 90.5, 136.7. EI-
HRMS Calcd for C5H7Br3: 303.8098. Found: 303.8101. 
1,1,6-Tribromo-1-hexene (1b; n = 4). Colorless liquid. Yield: 5.78 g (61%) starting with 5-
bromopentanal (4.90 g; 29.7 mmol). 1H NMR (CDCl3): d 1.56-1.64 (m, 2H), 1.86-1.93 (m, 2H), 2.12-
2.17 (m, 2H), 3.42 (t, J = 6.7 Hz, 2H), 6.39 (t, J = 7.2 Hz, 1H). 13C{1H} NMR (CDCl3): d 26.3, 31.9, 
32.1, 33.3, 89.5, 137.9. EI-HRMS Calcd for C6H9Br3: 317.8254. Found: 317.8251. 
1,1,7-Tribromo-1-heptene (1c; n = 5). Colorless liquid. Yield: 3.96 g (65%) starting with 6-
bromohexanal (3.26 g; 18.2 mmol). 1H NMR (CDCl3): d 1.41-1.52 (m, 4H), 1.84-1.91 (m, 2H), 2.09-
2.14 (m, 2H), 3.41 (t, J = 6.8 Hz, 2H), 6.39 (t, J = 7.3 Hz, 1H). 13C{1H} NMR (CDCl3): d 27.0, 27.6, 
32.5, 32.8, 33.6, 89.1, 138.3. EI-HRMS Calcd for C7H11Br3: 331.8411. Found: 331.8405. 
1,1,8-Tribromo-1-octene (1d; n = 6). Colorless liquid. Yield: 1.78 g (61%) starting with 7-
bromoheptanal (1.62 g; 8.39 mmol). 1H NMR (CDCl3): d 1.31-1.38 (m, 2H), 1.41-1.49 (m, 4H), 1.83-
1.90 (m, 2H), 2.07-2.13 (m, 2H), 3.41 (t, J = 6.8 Hz, 2H), 6.38 (t, J = 7.3 Hz, 1H). 13C{1H} NMR 
(CDCl3): d 27.6, 27.9, 28.2, 32.7, 32.9, 33.9, 88.8, 138.6. EI-HRMS Calcd for C8H13Br3: 345.8567. 
Found: 345.8570. 
1,1,9-Tribromo-1-nonene (1e; n = 7). Colorless liquid. Yield: 5.64 g (77%) starting with 8-
bromooctanal (4.18 g; 20.2 mmol). 1H NMR (CDCl3): d 1.31-1.47 (m, 8H), 1.82-1.89 (m, 2H), 2.07-2.12 
(m, 2H), 3.41 (t, J = 6.8 Hz, 2H), 6.38 (t, J = 7.2 Hz, 1H). 13C{1H} NMR (CDCl3): d 27.7, 28.1, 28.5, 
28.8, 32.7, 32.9, 34.0, 88.7, 138.7. EI-HRMS Calcd for C9H15Br3: 359.8724. Found: 359.8718. 
1,1,10-Tribromo-1-decene (1f; n = 8). Colorless liquid. Yield: 4.66 g (63%) starting with 9-
bromononanal (4.34 g; 19.6 mmol). 1H NMR (CDCl3): d 1.28-1.47 (m, 10H), 1.82-1.89 (m, 2H), 2.06-
2.12 (m, 2H), 3.41 (t, J = 6.8 Hz, 2H), 6.39 (t, J = 7.3 Hz, 1H). 13C{1H} NMR (CDCl3): d 27.8, 28.1, 
28.7, 28.9, 29.2, 32.8, 33.0, 34.1, 88.6, 138.9. EI-HRMS Calcd for C10H17Br3: 373.8880. Found: 373.8881. 
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1,1,11-Tribromo-1-undecene (1g; n = 9). Colorless liquid. Yield: 3.06 g (66%) starting with 10-
bromodecanal (2.79 g; 11.9 mmol). 1H NMR (CDCl3): d 1.26-1.43 (m, 12H), 1.82-1.89 (m, 2H), 2.06-
2.12 (m, 2H), 3.41 (t, J = 6.9 Hz, 2H), 6.38 (t, J = 7.2 Hz, 1H). 13C{1H} NMR (CDCl3): d 27.8, 28.1, 
28.7, 29.0, 29.2, 29.3, 32.8, 33.0, 34.1, 88.5, 138.9. EI-HRMS Calcd for C11H19Br3: 387.9037. Found: 
387.9037. 
1,1,13-Tribromo-1-tridecene (1h; n = 11). Colorless liquid. Yield: 4.68 g (68%) starting with 12-
bromododecanal (4.32 g; 16.4 mmol). 1H NMR (CDCl3): d 1.26-1.46 (m, 16H), 1.82-1.89 (m, 2H), 2.06-
2.11 (m, 2H), 3.41 (t, J = 6.9 Hz, 2H), 6.38 (t, J = 7.2 Hz, 1H). 13C{1H} NMR (CDCl3): d 27.8, 28.2, 
28.8, 29.1, 29.3, 29.4, 29.49, 29.50, 32.9, 33.0, 34.1, 88.5, 138.9. EI-HRMS Calcd for C13H23Br3: 
415.9350. Found: 415.9356. 
Preparation of (Z)-3,w-Dibromo-1,3-alkadienes (2a-h). To a suspension of (CH2=CH)ZnCl in THF, 
prepared from dry ZnCl2 (28 mmol) and vinylmagnesium chloride (2.0 M THF solution; 12 mL; 24 
mmol), was added a solution of 1,1,w-tribromo-1-alkene 1 (8.0 mmol) and Pd(PPh3)4 (0.20 mmol) in 
THF (16 mL) at 0 °C. After stirring the mixture for 4.5 h at room temperature, the reaction mixture was 
diluted with hexane, filtered, and evaporated to dryness. The residue was purified by silica gel 
chromatography (with hexane), and further purified by recycle HPLC to give the title compound. The 
characterization data of 2a-h are given below. 
(Z)-3,7-Dibromo-1,3-heptadiene (2a; n = 3). Colorless liquid. Yield: 1.10 g (54%). 1H NMR 
(CDCl3): d 1.99-2.06 (m, 2H), 2.46-2.52 (m, 2H), 3.43 (t, J = 6.8 Hz, 2H), 5.20 (d, J = 10.4 Hz, 1H), 
5.56 (d, J = 16.3 Hz, 1H), 5.98 (t, J = 7.2 Hz, 1H), 6.32 (dd, J = 16.3 and 10.4 Hz, 1H). 13C{1H} NMR 
(CDCl3): d 30.3, 31.5, 32.9, 118.2, 127.4, 132.7, 135.7. EI-HRMS Calcd for C7H10Br2: 251.9149. Found: 
251.9144. 
(Z)-3,8-Dibromo-1,3-octadiene (2b; n = 4). Colorless liquid. Yield: 1.16 g (54%). 1H NMR (CDCl3): 
d 1.58-1.66 (m, 2H), 1.87-1.94 (m, 2H), 2.34-2.39 (m, 2H), 3.43 (t, J = 6.7 Hz, 2H), 5.19 (d, J = 10.5 
Hz, 1H), 5.55 (d, J = 16.3 Hz, 1H), 5.97 (t, J = 7.1 Hz, 1H), 6.31 (dd, J = 16.3 and 10.5 Hz, 1H). 
13C{1H} NMR (CDCl3): d 26.9, 30.6, 32.2, 33.6, 117.7, 126.6, 134.0, 135.7. EI-HRMS Calcd for 
C8H12Br2: 265.9306. Found: 265.9303. 
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(Z)-3,9-Dibromo-1,3-nonadiene (2c; n = 5). Colorless liquid. Yield: 1.17 g (52%). 1H NMR 
(CDCl3): d 1.47-1.50 (m, 4H), 1.85-1.92 (m, 2H), 2.31-2.36 (m, 2H), 3.41 (t, J = 6.8 Hz, 2H), 5.17 (d, J 
= 10.5 Hz, 1H), 5.54 (d, J = 16.3 Hz, 1H), 5.98 (t, J = 7.2 Hz, 1H), 6.31 (dd, J = 16.3 and 10.5 Hz, 1H).  
13C{1H} NMR (CDCl3): d 27.5, 27.8, 31.3, 32.6, 33.7, 117.5, 126.2, 134.5, 135.8. EI-HRMS Calcd for 
C9H14Br2: 279.9462. Found: 279.9467. 
(Z)-3,10-Dibromo-1,3-decadiene (2d; n = 6). Colorless liquid. Yield: 1.21 g (51%). 1H NMR 
(CDCl3): d 1.32-1.51 (m, 6H), 1.83-1.90 (m, 2H), 2.30-2.35 (m, 2H), 3.41 (t, J = 6.9 Hz, 2H), 5.17 (d, J 
= 10.5 Hz, 1H), 5.53 (d, J = 16.3 Hz, 1H), 5.97 (t, J = 7.1 Hz, 1H), 6.31 (dd, J = 16.3 and 10.5 Hz, 1H). 
13C{1H} NMR (CDCl3): d 28.0, 28.2, 28.4, 31.4, 32.7, 34.0, 117.3, 126.1, 134.9, 135.8. EI-HRMS Calcd 
for C10H16Br2: 293.9619. Found: 293.9617. 
(Z)-3,11-Dibromo-1,3-undecadiene (2e; n = 7). Colorless liquid. Yield: 1.56 g (63%). 1H NMR 
(CDCl3): d 1.31-1.49 (m, 8H), 1.82-1.89 (m, 2H), 2.29-2.34 (m, 2H), 3.41 (t, J = 6.9 Hz, 2H), 5.16 (d, J 
= 10.5 Hz, 1H), 5.53 (d, J = 16.3 Hz, 1H), 5.98 (t, J = 7.1 Hz, 1H), 6.31 (dd, J = 16.3 and 10.5 Hz, 1H). 
13C{1H} NMR (CDCl3): d 28.1, 28.2, 28.6, 29.0, 31.5, 32.8, 34.0, 117.2, 126.0, 135.0, 135.8. EI-HRMS 
Calcd for C11H18Br2: 307.9775. Found: 307.9777. 
(Z)-3,12-Dibromo-1,3-dodecadiene (2f; n = 8). Colorless liquid. Yield: 1.30g (50%). 1H NMR 
(CDCl3): d 1.26-1.46 (m, 10H), 1.82-1.89 (m, 2H), 2.28-2.34 (m, 2H), 3.41 (t, J = 6.8 Hz, 2H), 5.16 (d, 
J = 10.5 Hz, 1H), 5.53 (d, J = 16.3 Hz, 1H), 5.98 (t, J = 7.1 Hz, 1H), 6.31 (dd, J = 16.3 and 10.5 Hz, 
1H). 13C{1H} NMR (CDCl3): d 28.2, 28.3, 28.7, 29.15, 29.24, 31.5, 32.8, 34.1, 117.2, 125.9, 135.2, 135.9. 
EI-HRMS Calcd for C12H20Br2: 321.9932. Found: 321.9931. 
(Z)-3,13-Dibromo-1,3-tridecadiene (2g; n = 9). Colorless liquid. Yield: 1.84 g (68%). 1H NMR 
(CDCl3): d 1.30-1.34 (m, 8H), 1.39-1.46 (m, 4H), 1.82-1.89 (m, 2H), 2.28-2.34 (m, 2H), 3.41 (t, J = 6.9 
Hz, 2H), 5.16 (d, J = 10.5 Hz, 1H), 5.53 (d, J = 16.3 Hz, 1H), 5.98 (t, J = 7.1 Hz, 1H), 6.31 (dd, J = 
16.3 and 10.5 Hz, 1H). 13C{1H} NMR (CDCl3): d 28.1, 28.3, 28.7, 29.2, 29.28, 29.32, 31.5, 32.8, 34.1, 
117.1, 125.8, 135.2, 135.9. EI-HRMS Calcd for C13H22Br2: 336.0088. Found: 336.0091. 
(Z)-3,15-Dibromo-1,3-pentadecadiene (2h; n = 11). Colorless liquid. Yield: 1.64 g (56%). 1H NMR 
(CDCl3): d 1.28-1.47 (m, 16H), 1.82-1.89 (m, 2H), 2.28-2.34 (m, 2H), 3.41 (t, J = 6.9 Hz, 2H), 5.15 (d, 
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J = 10.5 Hz, 1H), 5.52 (d, J = 16.3 Hz, 1H), 5.98 (t, J = 7.1 Hz, 1H), 6.31 (dd, J = 16.3 and 10.5 Hz, 
1H). 13C{1H} NMR (CDCl3): d 28.2, 28.4, 28.8, 29.3, 29.450, 29.455, 29.53 (2C), 31.6, 32.9, 34.1, 117.1, 
125.8, 135.3, 135.9. EI-HRMS Calcd for C15H26Br2: 364.0401. Found: 364.0404. 
Preparation of Malonate-Tethered Bromodienes 3a-h. A general procedure is given below. To a 
solution of NaH (4.9 mmol) in DMF (10 mL) was added dimethyl malonate (4.9 mmol) at 0 °C. After 
gas evolution was ceased, dibromoalkadiene 2 (4.0 mmol) was added to the solution by means of 
syringe under nitrogen. The mixture was stirred at room temperature for 20 h. After quenching with 
saturated NH4Claq, the reaction mixture was extracted with Et2O twice and the combined organic layer 
was washed with H2O and NaClaq, dried over MgSO4, filtered, and evaporated under reduced pressure. 
The residue was purified by silica gel chromatography (hexane/ethyl acetate = 4/1) to afford the 
malonate-tethered bromodiene 3. The characterization data of 3a-h are given below. 
Dimethyl 2-((Z)-5-Bromo-4,6-heptadienyl)-1,3-propanedioate (3a; n = 3). Colorless liquid. Yield: 
854 mg (70%). 1H NMR (CDCl3): d 1.43-1.53 (m, 2H), 1.92-1.98 (m, 2H), 2.33-2.38 (m, 2H), 3.39 (t, J 
= 7.5 Hz, 1H), 3.74 (s, 6H), 5.18 (d, J = 10.4 Hz, 1H), 5.54 (d, J = 16.3 Hz, 1H), 5.96 (t, J = 7.1 Hz, 
1H), 6.30 (dd, J = 16.3 and 10.4 Hz, 1H). 13C{1H} NMR (CDCl3): d 26.1, 28.4, 31.1, 51.5, 52.6, 117.7, 
126.6, 133.8, 135.7, 169.8. Anal. Calcd for C12H17BrO4: C, 47.23; H, 5.61. Found: C, 47.23; H, 5.57. ESI-
HRMS Calcd for C12H17BrO4Na: 327.0208 (M+Na). Found: 327.0220. 
Dimethyl 2-((Z)-6-Bromo-5,7-octadienyl)-1,3-propanedioate (3b; n = 4). Colorless liquid. Yield: 
1.02 g (80%). 1H NMR (CDCl3): d 1.32-1.40 (m, 2H), 1.45-1.52 (m, 2H), 1.90-1.96 (m, 2H), 2.30-2.35 
(m, 2H), 3.37 (t, J = 7.5 Hz, 1H), 3.74 (s, 6H), 5.17 (d, J = 10.5 Hz, 1H), 5.53 (d, J = 16.3 Hz, 1H), 
5.96 (t, J = 7.3 Hz, 1H), 6.31 (dd, J = 16.3 and 10.5 Hz, 1H). 13C{1H} NMR (CDCl3): d 27.0, 27.9, 28.7, 
31.2, 51.6, 52.6, 117.5, 126.3, 134.5, 135.8, 169.9. Anal. Calcd for C13H19BrO4: C, 48.92; H, 6.00. Found: 
C, 48.77; H, 5.97. EI-HRMS Calcd for C13H19BrO4: 318.0467. Found: 318.0468. 
Dimethyl 2-((Z)-7-Bromo-6,8-nonadienyl)-1,3-propanedioate (3c; n = 5). Colorless liquid. Yield: 
1.00 g (75%). 1H NMR (CDCl3): d 1.29-1.50 (m, 6H), 1.88-1.93 (m, 2H), 2.28-2.33 (m, 2H), 3.36 (t, J = 
7.6 Hz, 1H), 3.74 (s, 6H), 5.16 (d, J = 10.6 Hz, 1H), 5.52 (d, J = 16.3 Hz, 1H), 5.96 (t, J = 7.1 Hz, 1H), 
6.31 (dd, J = 16.3 and 10.6 Hz, 1H). 13C{1H} NMR (CDCl3): d 27.1, 27.9, 28.69, 28.71, 31.3, 51.6, 52.4, 
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117.2, 126.0, 134.7, 135.8, 169.9. Anal. Calcd for C14H21BrO4: C, 50.46; H, 6.35. Found: C, 50.37; H, 
6.29. ESI-HRMS Calcd for C14H21BrO4Na: 355.0515 (M+Na). Found: 355.0516. 
Dimethyl 2-((Z)-8-Bromo-7,9-decadienyl)-1,3-propanedioate (3d; n = 6). Colorless liquid. Yield: 
1.01 g (73%). 1H NMR (CDCl3): d 1.29-1.34 (m, 6H), 1.40-1.47 (m, 2H), 1.87-1.93 (m, 2H), 2.28-2.33 
(m, 2H), 3.36 (t, J = 7.5 Hz, 1H), 3.74 (s, 6H), 5.16 (d, J = 10.3 Hz, 1H), 5.53 (d, J = 16.3 Hz, 1H), 
5.97 (t, J = 7.2 Hz, 1H), 6.31 (dd, J = 16.3 and 10.3 Hz, 1H). 13C{1H} NMR (CDCl3): d 27.3, 28.2, 28.8, 
28.9, 29.0, 31.5, 51.7, 52.5, 117.2, 126.0, 135.0, 135.9, 170.0. Anal. Calcd for C15H23BrO4: C, 51.88; H, 
6.68. Found: C, 51.72; H, 6.60. EI-HRMS Calcd for C15H23BrO4: 346.0780. Found: 346.0781. 
Dimethyl 2-((Z)-9-Bromo-8,10-undecadienyl)-1,3-propanedioate (3e; n = 7). Colorless liquid. 
Yield: 1.37 g (95%). 1H NMR (CDCl3): d 1.26-1.32 (m, 8H), 1.39-1.47 (m, 2H), 1.87-1.92 (m, 2H), 
2.28-2.33 (m, 2H), 3.36 (t, J = 7.6 Hz, 1H), 3.74 (s, 6H), 5.16 (d, J = 10.4 Hz, 1H), 5.53 (d, J = 16.3 Hz, 
1H), 5.97 (t, J = 7.1 Hz, 1H), 6.31 (dd, J = 16.3 and 10.4 Hz, 1H). 13C{1H} NMR (CDCl3): d 27.3, 28.3, 
28.8, 29.09, 29.11 (2C), 31.5, 51.7, 52.5, 117.2, 125.9, 135.2, 135.9, 170.0. Anal. Calcd for C16H25BrO4: 
C, 53.19; H, 6.97. Found: C, 52.66; H, 6.91. EI-HRMS Calcd for C16H25BrO4: 360.0936. Found: 
360.0936. 
Dimethyl 2-((Z)-10-Bromo-9,11-dodecadienyl)-1,3-propanedioate (3f; n = 8). Colorless liquid. 
Yield: 1.20 g (80%). 1H NMR (CDCl3): d 1.26-1.33 (m, 10H), 1.39-1.47 (m, 2H), 1.87-1.92 (m, 2H), 
2.28-2.33 (m, 2H), 3.36 (t, J = 7.6 Hz, 1H), 3.74 (s, 6H), 5.16 (d, J = 10.5 Hz, 1H), 5.53 (d, J = 16.4 Hz, 
1H), 5.98 (t, J = 7.1 Hz, 1H), 6.31 (dd, J = 16.4 and 10.5 Hz, 1H). 13C{1H} NMR (CDCl3): d 27.4, 28.3, 
28.9, 29.18, 29.21, 29.22, 29.3, 31.5, 51.8, 52.5, 117.2, 125.9, 135.2, 135.9, 170.0. Anal. Calcd for 
C17H27BrO4: C, 54.41; H, 7.25. Found: C, 54.48; H, 7.27. EI-HRMS Calcd for C17H27BrO4: 374.1093. 
Found: 374.1093. 
Dimethyl 2-((Z)-11-Bromo-10,12-tridecadienyl)-1,3-propanedioate (3g; n = 9). Colorless liquid. 
Yield: 1.42 g (91%). 1H NMR (CDCl3): d 1.28-1.33 (m, 12H), 1.40-1.47 (m, 2H), 1.87-1.92 (m, 2H), 
2.28-2.33 (m, 2H), 3.36 (t, J = 7.6 Hz, 1H), 3.74 (s, 6H), 5.15 (d, J = 10.4 Hz, 1H), 5.52 (d, J = 16.3 Hz, 
1H), 5.98 (t, J = 7.3 Hz, 1H), 6.31 (dd, J = 16.3 and 10.4 Hz, 1H). 13C{1H} NMR (CDCl3): d 27.3, 28.3, 
28.8, 29.16, 29.21, 29.25, 29.34, 29.38, 31.5, 51.7, 52.4, 117.1, 125.8, 135.2, 135.9, 170.0. Anal. Calcd 
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for C18H29BrO4: C, 55.53; H, 7.51. Found: C, 55.60; H, 7.39. EI-HRMS Calcd for C18H29BrO4: 388.1249. 
Found: 388.1247. 
Dimethyl 2-((Z)-13-Bromo-12,14-pentadecadienyl)-1,3-propanedioate (3h; n = 11). Colorless 
liquid. Yield: 1.29 g (77%). 1H NMR (CDCl3): d 1.26-1.35 (m, 16H), 1.40-1.47 (m, 2H), 1.87-1.92 (m, 
2H), 2.28-2.34 (m, 2H), 3.36 (t, J = 7.6 Hz, 1H), 3.74 (s, 6H), 5.15 (d, J = 10.4 Hz, 1H), 5.52 (d, J = 
16.3 Hz, 1H), 5.98 (t, J = 7.1 Hz, 1H), 6.31 (dd, J = 16.3 and 10.4 Hz, 1H). 13C{1H} NMR (CDCl3): d 
27.4, 28.4, 28.9, 29.2, 29.29, 29.32, 29.4, 29.51, 29.54, 29.6, 31.6, 51.8, 52.5, 117.1, 125.8, 135.3, 
135.9, 170.0. Anal. Calcd for C20H33BrO4: C, 57.55; H, 7.97. Found: C, 57.69; H, 7.84. ESI-HRMS Calcd 
for C20H33BrO4Na: 439.1454 (M+Na). Found: 439.1449. 
2-((Z)-10-Bromo-9,11-dodecadienyl)-1,3-benzodithiole-1,1,3,3-tetraoxide (4f). To a mixture of 
NaH (26 mg, 1.1 mmol) and BDT (240 mg, 1.1 mmol) in DMF (4.5 ml) was added 
dibromododecadiene 2f (274 mg, 844 µmol) by means of syringe under nitrogen. After stirring the 
mixture for 16 h at 80 °C, the reaction mixture was extracted with ethyl acetate twice and the combined 
organic layer was washed with H2O and NaClaq, dried over MgSO4, filtered, and evaporated under 
reduced pressure. The residue was purified by recycle HPLC to afford 4f (263 mg, 570  mol, 68%) as 
a white solid. m. p., 67-69 °C. 1H NMR (CDCl3): d 1.33-1.50 (m, 10H), 1.75-1.80 (m, 2H), 2.30-2.34 (m, 
4H), 4.36 (t, J = 7.1 Hz, 1H), 5.16 (d, J = 10.4 Hz, 1H), 5.53 (d, J = 16.3 Hz, 1H), 5.99 (t, J = 7.0 Hz, 
1H), 6.32 (dd, J = 16.3 and 10.4 Hz, 1H) 7.91-7.94 (m, 2H), 8.02-8.05 (m, 2H). 13C{1H} NMR (CDCl3): 
d 22.1, 25.8, 28.2, 28.8, 29.00, 29.04, 29.1, 31.4, 73.7, 117.1, 122.5, 125.8, 135.1, 135.78, 135.79, 
137.6. Anal. Calcd for C19H25BrO4S2: C, 49.46; H, 5.46. Found: C, 49.80; H, 5.40. EI-HRMS Calcd for 
C19H25BrO4S2: 460.0378. Found: 460.0367. 
Palladium-Catalyzed Reaction of Malonate-Tethered Bromodienes 3a-h. A general procedure is 
given below. To a mixture of Pd2(dba)4 (17.5 µmol), dpbp (19.2 µmol), and KOtBu (385 µmol) in THF 
(250 mL) was added malonate-tethered bromodiene 3 (350 µmol, 1.4 mM) by means of syringe under 
nitrogen. After stirring the mixture for 20 h at 30 °C, the reaction mixture was concentrated, filtered 
through a short pad of silica gel, and evaporated to dryness. The crude product was purified by recycle 
HPLC to afford the corresponding endocyclic allenes 5, 6, and 7. The characterization data of the cyclic 
allenic products (5, 6, and 7) are listed below. 
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Dimethyl 2,2-(2,3-Octadien-1,8-diyl)-1,3-propanedioate (5b; n = 4). Colorless liquid. Yield: 19.2 
mg (23%). 1H NMR (CDCl3): d 1.42-1.58 (m, 4H), 1.93-2.06 (m, 3H), 2.36-2.46 (m, 1H), 2.57-2.63 (m, 
1H), 2.81-2.87 (m, 1H), 3.71 (s, 3H), 3.72 (s, 3H), 4.94-5.01 (m, 2H). 13C{1H} NMR (CDCl3): d 18.9, 
24.1, 24.8, 28.4, 31.6, 52.5, 52.6, 57.0, 85.3, 87.4, 172.2, 172.6, 209.8. ESI-HRMS Calcd for 
C13H18O4Na: 261.1103 (M+Na). Found: 261.1106. 
Dimethyl 2,2-(2,3-Nonadien-1,9-diyl)-1,3-propanedioate (5c; n = 5). Colorless liquid. Yield: 9.7 
mg (11%). 1H NMR (CDCl3): d 1.29-1.84 (m, 7H), 1.88-1.96 (m, 1H), 2.04-2.11 (m, 1H), 2.32-2.41 (m, 
1H), 2.61-2.72 (m, 2H), 3.72 (s, 3H), 3.73 (s, 3H), 4.98-5.05 (m, 1H), 5.29-5.32 (m, 1H). 13C{1H} NMR 
(CDCl3): d 20.0, 20.6, 28.3, 29.7, 29.8, 32.6, 52.5, 52.6, 55.5, 87.0, 92.9, 172.0, 172.7, 205.9. EI-HRMS 
Calcd for C14H20O4: 252.1362. Found: 252.1363. 
Dimethyl 2,2-(2,3-Decadien-1,10-diyl)-1,3-propanedioate (5d; n = 6). Colorless liquid. Yield: 16.8 
mg (18%). 1H NMR (CDCl3): d 1.18-1.62 (m, 8H), 1.78-1.96 (m, 2H), 2.04-2.15 (m, 2H), 2.59 (dd, J = 
14.1 and 11.6 Hz, 1H), 2.79 (dt, J = 14.1 and 4.4 Hz, 1H), 3.71 (s, 3H), 3.74 (s, 3H), 5.01-5.08 (m, 1H), 
5.26-5.31 (m, 1H). 13C{1H} NMR (CDCl3): d 20.4, 26.0, 26.1, 26.4, 26.8, 30.9, 34.0, 52.5, 52.6, 57.2, 
87.4, 91.4, 171.8, 172.2, 206.0. EI-HRMS Calcd for C15H22O4: 266.1518. Found: 266.1516. 
Dimethyl 2,2-(2,3-Undecadien-1,11-diyl)-1,3-propanedioate (5e; n = 7). Colorless liquid. Yield: 
30.4 mg (31%). 1H NMR (CDCl3): d 0.97-1.59 (m, 10H), 1.74-1.82 (m, 1H), 1.93-2.17 (m, 3H), 2.55 (dd, 
J = 13.9 and 11.6 Hz, 1H), 2.68-2.73 (m, 1H), 3.71 (s, 3H), 3.74 (s, 3H), 4.61-4.67 (m, 1H), 4.89-4.96 
(m, 1H). 13C{1H} NMR (CDCl3): d 19.1, 21.4, 22.3, 25.9, 26.48, 26.54, 27.3, 32.1, 52.5, 52.6, 56.8, 83.8, 
89.2, 171.7, 171.8, 208.4. Anal. Calcd for C16H24O4: C, 68.54; H, 8.63. Found: C, 68.28; H, 8.74. EI-
HRMS Calcd for C16H24O4: 280.1675. Found: 280.1675. 
Dimethyl 2,2-(2,3-Dodecadien-1,12-diyl)-1,3-propanedioate (5f; n = 8). Colorless liquid. Yield: 
53.6 mg (52%). 1H NMR (CDCl3): d 1.06-1.15 (m, 1H), 1.26-1.62 (m, 11H), 1.90-2.12 (m, 4H), 2.55 (dd, 
J = 14.6 and 11.4 Hz, 1H), 2.77 (dtd, J = 14.6, 4.4, and 1.2 Hz, 1H), 3.71 (s, 3H), 3.73 (s, 3H), 4.74-
4.81 (m, 1H), 5.12-5.17 (m, 1H). 13C{1H} NMR (CDCl3): d 21.7, 25.0, 26.1, 26.9, 27.2, 27.9, 28.6, 30.8, 
31.7, 52.45, 52.51, 57.4, 85.7, 91.4, 171.8 (2C), 206.1. Anal. Calcd for C17H26O4: C, 69.36; H, 8.90.  
Found: C, 69.28; H, 9.05. EI-HRMS Calcd for C17H26O4: 294.1831. Found: 294.1824. 
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Dimethyl 2,2-(2,3-Tridecadien-1,13-diyl)-1,3-propanedioate (5g; n = 9). Colorless liquid. Yield: 
45.3 mg (42%). 1H NMR (CDCl3): d 0.73-0.90 (m, 1H), 1.14-1.57 (m, 13H), 1.87-2.04 (m, 4H), 2.58 (dd, 
J = 14.5 and 11.6 Hz, 1H), 2.78 (dtd, J = 14.5, 4.4, and 0.9 Hz, 1H), 3.72 (s, 3H), 3.73 (s, 3H), 4.63-
4.70 (m, 1H), 5.02-5.08 (m, 1H). 13C{1H} NMR (CDCl3): d 20.7, 23.2, 23.9, 26.0, 26.37, 26.40, 27.16, 
27.18, 31.6, 32.4, 52.5, 52.6, 57.2, 84.5, 91.3, 171.8, 171.9, 206.1. Anal. Calcd for C18H28O4: C, 70.10; H, 
9.15. Found: C, 70.00; H, 9.11. EI-HRMS Calcd for C18H28O4: 308.1988. Found: 308.1989. 
Dimethyl 2,2-(2,3-Pentadecadien-1,15-diyl)-1,3-propanedioate (5h; n = 11). Colorless liquid. 
Yield: 38.9 mg (33%). 1H NMR (CDCl3): d 1.07-1.43 (m, 18H), 1.82-2.03 (m, 4H), 2.56 (dd, J = 14.2 
and 9.8 Hz, 1H), 2.71 (ddd, J = 14.2, 6.0, and 3.2 Hz, 1H), 3.72 (s, 3H), 3.73(s, 3H), 4.69-4.71 (m, 1H), 
5.07-5.13 (m, 1H). 13C{1H} NMR (CDCl3): d 23.6, 24.2, 24.4, 25.9, 26.0, 26.2, 26.3, 27.4, 27.5, 29.0, 
31.9, 32.9, 52.41, 52.44, 57.3, 84.6, 91.2, 171.81, 171.84, 206.2. EI-HRMS Calcd for C20H32O4: 336.2301. 
Found: 336.2302. 
5,5,13,13-Tetra(methoxycarbonyl)cyclohexadeca-1,2,9,10-tetraene (6a; n = 3). Diastereomeric 
mixture (13C NMR signals not completely resolved).17 Colorless liquid. Yield: 23.5 mg (30%). 1H NMR 
(CDCl3): d 1.02-1.10 (m, 1H), 1.17-1.41 (m, 3H), 1.79-2.12 (m, 8H), 2.49-2.55 (m, 2H), 2.66-2.72 (m, 
2H), 3.70-3.72(s, 12H), 4.63-4.81 (m, 2H), 4.97-5.10 (m, 2H). 13C{1H} NMR (CDCl3): d 23.9, 24.8, 29.7, 
31.0, 31.1, 31.5, 31.8, 32.1, 52.5, 52.57, 52.64, 57.0, 84.3, 84.8, 90.5, 90.6, 171.51, 171.55, 171.60, 
171.62, 205.7, 206.0. Anal. Calcd for C24H32O8: C, 64.27; H, 7.19. Found: C, 64.08; H, 7.25. EI-HRMS 
Calcd for C24H32O8: 448.2097. Found: 448.2098. 
5,5,14,14-Tetra(methoxycarbonyl)cyclooctadeca-1,2,10,11-tetraene (6b; n = 4). Diastereomeric 
mixture (13C NMR signals not completely resolved).17 Colorless liquid. Yield: 13.3 mg (16%). 1H NMR 
(CDCl3): d 0.94-1.70 (m, 8H), 1.82-2.08 (m, 8H), 2.50-2.57 (m, 2H), 2.68-2.73 (m, 2H), 3.72-3.75 (m, 
12H), 4.65-4.80 (m, 2H), 5.04-5.15 (m, 2H). 13C{1H} NMR (CDCl3): d 23.7, 24.1, 28.4, 29.0, 30.2, 30.8, 
31.7, 31.9, 32.6, 32.9, 52.50, 52.54, 52.6, 57.0, 57.1, 84.6, 85.5, 90.7, 90.9, 171.6, 171.7, 205.7, 206.0. 
Anal. Calcd for C26H36O8: C, 65.53; H, 7.61. Found: C, 65.81; H, 7.77. EI-HRMS Calcd for C26H36O8: 
476.2410. Found: 476.2414. 
5,5,15,15-Tetra(methoxycarbonyl)cycloeicosa-1,2,11,12-tetraene (6c; n = 5). Diastereomeric 
mixture (13C NMR signals not completely resolved).17 Colorless liquid. Yield: 21.2 mg (24%). 1H NMR 
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(CDCl3): d 0.96-1.12 (m, 2H), 1.16-1.45 (m, 10H), 1.82-2.07 (m, 8H), 2.51-2.56 (m, 2H), 2.68-2.72 (m, 
2H), 3.72-3.73 (m, 12H), 4.65-4.75 (m, 2H), 5.01-5.09 (m, 2H). 13C{1H} NMR (CDCl3): d 24.0, 24.1, 
29.3, 29.5, 29.8, 30.1, 30.6, 30.7, 31.6, 31.7, 32.18, 32.22, 52.55, 52.60, 57.1, 57.2, 84.4, 84.8, 90.8, 
90.9, 171.7, 205.8, 205.9. Anal. Calcd for C28H40O8: C, 66.65; H, 7.99. Found: C, 66.49; H, 8.12. EI-
HRMS Calcd for C28H40O8: 504.2723. Found: 504.2724. 
5,5,16,16-Tetra(methoxycarbonyl)cyclodocosa-1,2,12,13-tetraene (6d; n = 6). Diastereomeric 
mixture (13C NMR signals not completely resolved).17 Colorless liquid. Yield: 25.2 mg (27%). 1H NMR 
(CDCl3): d 0.96-1.38 (m, 16H), 1.84-2.02 (m, 8H), 2.50-2.56 (m, 2H), 2.68-2.74 (m, 2H), 3.72-3.73 (m, 
12H), 4.65-4.77 (m, 2H), 5.03-5.13 (m, 2H). 13C{1H} NMR (CDCl3): d 24.3, 24.4, 29.0, 29.6, 29.87, 
29.92, 30.3, 30.4, 30.6, 31.9, 32.6, 32.7, 52.50, 52.54, 57.11, 57.13, 84.6, 85.0, 90.99, 91.04, 171.8, 
205.78, 205.82. Anal. Calcd for C30H44O8: C, 67.64; H, 8.33. Found: C, 67.44; H, 8.38. EI-HRMS Calcd 
for C30H44O8: 532.3036. Found: 532.3037. 
5,5,17,17-Tetra(methoxycarbonyl)cyclotetracosa-1,2,13,14-tetraene (6e; n = 7). Diastereomeric 
mixture (13C NMR signals not completely resolved).17 Colorless liquid. Yield: 18.6 mg (19%). 1H NMR 
(CDCl3): d 0.97-1.43 (m, 20H), 1.83-2.05 (m, 8H), 2.51-2.57 (m, 2H), 2.66-2.72 (m, 2H), 3.72 (s, 6H), 
3.73(s, 6H), 4.66-4.75 (m, 2H), 5.02-5.10 (m, 2H). 13C{1H} NMR (CDCl3): d 24.1, 24.3, 29.4, 29.7, 
29.75, 29.82, 29.9, 30.3, 30.38, 30.43, 30.8, 31.6, 31.7, 31.8, 32.3, 52.5, 52.6, 57.18, 57.23, 84.5, 84.6, 
91.0, 91.1, 171.8, 205.8, 205.9. Anal. Calcd for C32H48O8: C, 68.54; H, 8.63. Found: C, 68.78; H, 8.83. 
EI-HRMS Calcd for C32H48O8: 560.3349. Found: 560.3353. 
5,5,18,18-Tetra(methoxycarbonyl)cyclohexacosa-1,2,14,15-tetraene (6f; n = 8). Diastereomeric 
mixture (13C NMR signals not completely resolved).17 Colorless liquid. Yield: 14.4 mg (14%). 1H NMR 
(CDCl3): d 1.02-1.37 (m, 24H), 1.86-2.03 (m, 8H), 2.50-2.57 (m, 2H), 2.67-2.72 (m, 2H), 3.71-3.73 (m, 
12H), 4.68-4.76 (m, 2H), 5.04-5.11 (m, 2H). 13C{1H} NMR (CDCl3): d 24.2, 24.3, 29.2, 29.6, 29.8, 30.0, 
30.17, 30.21, 30.3, 30.4, 30.5, 30.6, 31.9, 32.6, 52.49, 52.52, 57.2, 84.6, 84.8, 91.1, 171.8, 205.8. Anal. 
Calcd for C34H52O8: C, 69.36; H, 8.90. Found: C, 69.30; H, 9.09. EI-HRMS Calcd for C34H52O8: 588.3662. 
Found: 588.3658. 
5,5,19,19-Tetra(methoxycarbonyl)cyclooctacosa-1,2,15,16-tetraene (6g; n = 9). Diastereomeric 
mixture (13C NMR signals not completely resolved).17 Colorless liquid. Yield: 22.7 mg (21%). 1H NMR 
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(CDCl3): d 1.01-1.37 (m, 28H), 1.86-2.05 (m, 8H), 2.56 (dd, J = 14.3 and 9.8 Hz, 2H), 2.68 (ddd, J = 
14.3, 6.1, and 3.3 Hz, 2H), 3.71 (s, 6H), 3.72(s, 6H), 4.68-4.76 (m, 2H), 5.04-5.10 (m, 2H). 13C{1H} 
NMR (CDCl3): d 24.0, 24.1, 29.3, 29.5, 29.67, 29.72, 29.8, 29.97, 30.03, 30.1, 30.2, 30.3, 30.5, 31.8, 
32.4, 52.5, 57.2, 84.58, 84.64, 91.1, 171.8, 205.8. Anal. Calcd for C36H56O8: C, 70.10; H, 9.15. Found: C, 
70.08; H, 9.01. EI-HRMS Calcd for C36H56O8: 616.3975. Found: 616.3978. 
5,5,21,21-Tetra(methoxycarbonyl)cyclodotriaconta-1,2,17,18-tetraene (6h; n = 11). 
Diastereomeric mixture (13C NMR signals not completely resolved).17 Colorless liquid. Yield: 11.8 mg 
(10%). 1H NMR (CDCl3): d 1.04-1.41 (m, 36H), 1.86-2.05 (m, 8H), 2.55 (ddd, J = 14.3, 9.6, and 1.2 Hz, 
2H), 2.67 (ddd, J = 14.3, 6.2, and 3.3 Hz, 2H), 3.71 (s, 6H), 3.72(s, 6H), 4.70-4.78 (m, 2H), 5.04-5.10 
(m, 1H). 13C{1H} NMR (CDCl3): d 24.0, 29.20, 29.24, 29.57, 29.63, 29.7, 29.8, 29.85, 29.94, 30.02, 
30.07, 30.2, 30.3, 31.8, 32.4, 52.5, 57.3, 84.7, 91.1, 171.9, 205.8. Anal. Calcd for C40H64O8: C, 71.39; H, 
9.59. Found: C, 70.96; H, 9.56. EI-HRMS Calcd for C40H64O8: 672.4601. Found: 672.4602. 
5,5,13,13,21,21-Hexa(methoxycarbonyl)cyclotetracosa-1,2,9,10,17,18-hexaene (7a; n = 3). 
Diastereomeric mixture (13C NMR signals not completely resolved).17 Colorless liquid. Yield: 7.8 mg 
(10%). 1H NMR (CDCl3): d 1.19-1.35 (m, 6H), 1.86-2.08 (m, 12H), 2.56-2.67 (m, 6H), 3.71-3.74 (m, 
18H), 4.79-4.871 (m, 3H), 4.98-5.06 (m, 3H). 13C{1H} NMR (CDCl3): d 23.9, 29.4, 31.4, 32.6, 52.5, 57.3, 
84.8, 90.3, 171.6, 205.8, 205.9, 206.0. EI-HRMS Calcd for C36H48O12: 672.3146. Found: 672.3148. 
5,5,15,15,25,25-Hexa(methoxycarbonyl)cyclotriaconta-1,2,11,12,21,22-hexaene (7c; n = 5). 
Diastereomeric mixture (13C NMR signals not completely resolved).17 Colorless liquid. Yield: 6.2 mg 
(7%). 1H NMR (CDCl3): d 1.11-1.43 (m, 18H), 1.86-1.98 (m, 12H), 2.55-2.66 (m, 6H), 3.71-3.72 (m, 
18H), 4.78-4.85 (m, 3H), 5.03-5.08 (m, 3H). 13C{1H} NMR (CDCl3): d 23.6, 28.7, 28.9, 29.2, 31.8, 32.5, 
52.5, 57.5, 84.9, 90.8, 171.8, 205.8. EI-HRMS Calcd for C42H60O12: 756.4085. Found: 756.4085. 
5,5,16,16,27,27-Hexa(methoxycarbonyl)cyclotritriaconta-1,2,12,13,23,24-hexaene (7d; n = 6). 
Diastereomeric mixture (13C NMR signals not completely resolved).17 Colorless liquid. Yield: 8.4 mg 
(9%). 1H NMR (CDCl3): d 1.10-1.41 (m, 24H), 1.86-1.98 (m, 12H), 2.55-2.66 (m 6H), 3.715 (s, 9H), 
3.718 (s, 9H), 4.79-4.86 (m, 3H), 5.03-5.09 (m, 3H). 13C{1H} NMR (CDCl3): d 23.8, 28.7, 28.8, 29.1, 
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29.6, 31.9, 32.5, 52.5, 57.5, 84.9, 90.9, 171.8, 205.8. EI-HRMS Calcd for C45H66O12: 798.4554. Found: 
798.4552. 
2,2-(Dodecadien-1,12-diyl)-1,3-benzodithiole-1,1,3,3-tetraoxide (10f). To a mixture of Pd2(dba)4 
(5.5 mg, 11 µmol), dpbp (6.0mg, 12 µol), KOtBu (23.6 mg, 210 µmol) in THF (150 ml) was added 4f 
(96.9 mg, 210 µmol, 1.4 mM) by means of syringe under nitrogen. After stirring the mixture for 120 h 
at 30 °C, the reaction mixture was concentrated, filtered through a short pad of silica gel, and 
evaporated to dryness. The crude product was purified by recycle HPLC to afford 10f (53.2 mg, 140 
µmol, 67%) as colorless liquid. 1H NMR (CDCl3): d 1.21-1.86 (m, 12H), 2.02-2.15 (m, 2H), 2.26-2.38 
(m, 2H), 2.88 (dt, J = 15.3 and 4.3 Hz, 1H), 2.99 (dd, J = 15.3 and 10.6 Hz, 1H), 5.22-5.28 (m, 1H), 
5.43-5.50 (m, 1H) 7.88-7.93 (m, 2H), 7.98-8.04 (m, 2H). 13C{1H} NMR (CDCl3): d 21.1, 25.3, 25.7, 26.1, 
26.6, 26.7, 27.5, 29.0, 29.7, 79.5, 83.4, 92.6, 123.1, 123.2, 135.1, 135.2, 135.8, 136.3, 207.1. Anal. 
Calcd for C19H24O4S2: C, 59.97; H, 6.36. Found: C, 60.04; H, 6.36. EI-HRMS Calcd for C19H24O4S2: 
380.1116. Found: 380.1121. 
Palladium-Catalyzed Asymmetric Synthesis of Axially Chiral 5f and 10f. The asymmetric 
reactions were conducted in the same way as with the non-asymmetric reaction described above except 
for using a chiral ligand instead of achiral dpbp (see Table 3 for details). (S)-5f (entry 7, Table 3): [a]25D 
= +93.1 (c 0.73, CHCl3 for the sample of (S)-70% ee). Chiral HPLC Analysis Conditions: Chiralpak IC; 
eluent, hexane/iPrOH = 200/1; flow rate, 1.0 mL/min; t1 [(R)-enantiomer] = 20.8 min, t2 [(S)-enantiomer] 
= 40.7 min. (S)-10f (entry 10, Table 3): [a]25D = +56.9 (c 0.37, CHCl3 for the sample of (S)-51% ee). 
Chiral HPLC Analysis Conditions: Chiralpak IC; eluent, hexane/iPrOH = 9/1; flow rate, 1.0 mL/min; ; t1 
[(S)-enantiomer] = 20.0 min, t2 [(R)-enantiomer] = 31.9 min. 
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